PROVIDER PROFILE · NPI 1396822706

Jonathan GoldsteinM.D.

GastroenterologyRochester, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

165

Unique beneficiaries

—

Total services

177

Distinct HCPCS

Medicare payment

$13K

Peer benchmark

Total Medicare services vs. 1,360 Gastroenterology providers in NY — bottom quintile (cohort median 521).

PRESCRIBING · PART D · 2024

Total Rx claims

892

Beneficiaries

—

Total drug cost

$511K

Distinct drugs

Brand share

47.9%

Top prescribed drugs

Sodium, Potassium,mag Sulfates304 claims

Pantoprazole Sodium175 claims

Famotidine97 claims

Omeprazole55 claims

Mesalamine36 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$42K

Payment records

By payment type

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$40K

Food and Beverage$949

Travel and Lodging$588

REFERRAL NETWORK

Where Jonathan Goldstein's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 5 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
UNIVERSITY OF ROCHESTER	98	456
ROCHESTER GENERAL HOSPITAL	24	74

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
HIGHLAND HOSPITAL OF ROCHESTER	96	264
UNIVERSITY OF ROCHESTER	83	334
WESTFALL SURGERY CENTER LLP	22	67
ADJEI, OSBERT	14	37
Jennifer Findeis-Hosey Pathology · Rochester, NY	11	45

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history